Kris Gevaert Selected Research

Peptide Hydrolases (Proteases)

1/2019	Pollens destroy respiratory epithelial cell anchors and drive alphaherpesvirus infection.
8/2015	Proteomic Identification of Cysteine Cathepsin Substrates Shed from the Surface of Cancer Cells.
7/2015	Fast profiling of protease specificity reveals similar substrate specificities for cathepsins K, L and S.
7/2013	Mapping proteolytic processing in the secretome of gastric cancer-associated myofibroblasts reveals activation of MMP-1, MMP-2, and MMP-3.
9/2012	A catalogue of putative HIV-1 protease host cell substrates.
8/2011	Human and mouse granzyme M display divergent and species-specific substrate specificities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kris Gevaert Research Topics

Disease

20	Neoplasms (Cancer) 02/2024 - 05/2008
13	Infections 01/2023 - 07/2002
8	Inflammation (Inflammations) 12/2018 - 12/2008
4	Bacterial Infections (Bacterial Infection) 01/2023 - 12/2008
4	Carcinogenesis 10/2015 - 08/2014
3	Alzheimer Disease (Alzheimer's Disease) 07/2016 - 11/2009
3	Sepsis (Septicemia) 03/2016 - 05/2011
3	Parkinson Disease (Parkinson's Disease) 10/2014 - 09/2012
2	Carcinoma (Carcinomatosis) 02/2024 - 01/2019
2	Ovarian Neoplasms (Ovarian Cancer) 10/2023 - 01/2021
2	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2013
2	Hypoxia (Hypoxemia) 01/2017 - 01/2010
2	Communicable Diseases (Infectious Diseases) 03/2016 - 01/2014
2	Pathologic Processes 07/2015 - 05/2013
2	Inborn Genetic Diseases (Disease, Hereditary) 04/2015 - 08/2014
2	Q Fever (Fever, Q) 01/2012 - 02/2011
2	Neuroblastoma 12/2010 - 07/2008
2	Salmonella Infections (Salmonellosis) 12/2009 - 12/2008
1	Mania (Manias) 12/2022
1	Immune System Diseases (Immune Disorders) 08/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Triple Negative Breast Neoplasms 01/2021
1	Cognitive Dysfunction 01/2021
1	Dehydration (Water Stress) 01/2020
1	Confusion (Bewilderment) 01/2020
1	Chronic Disease (Chronic Diseases) 01/2020
1	Multiple Sclerosis 01/2020
1	Multiple Myeloma 01/2020
1	Asthma (Bronchial Asthma) 01/2020
1	Rheumatoid Arthritis 01/2020
1	Wounds and Injuries (Trauma) 03/2019
1	Disease Progression 01/2019
1	Starvation 12/2018
1	Chronic Renal Insufficiency 01/2018
1	Obesity 01/2018
1	Tauopathies 01/2018
1	Vascular Calcification 01/2018
1	Osteoporosis 01/2018
1	Infertility (Sterility) 02/2017

Drug/Important Bio-Agent (IBA)

35	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2002
14	ProteomeIBA 01/2023 - 07/2008
8	Peptides (Polypeptides)IBA 01/2021 - 10/2005
7	Phosphotransferases (Kinase)IBA 01/2021 - 09/2012
6	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 08/2011
5	EnzymesIBA 12/2022 - 07/2012
4	GlucocorticoidsIBA 02/2024 - 01/2018
3	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 02/2024 - 01/2018
3	MicroRNAs (MicroRNA)IBA 01/2021 - 12/2010
3	CaspasesIBA 01/2020 - 01/2002
3	Amyloid (Amyloid Fibrils)IBA 11/2016 - 07/2012
3	Biomarkers (Surrogate Marker)IBA 07/2015 - 08/2014
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2014 - 01/2012
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 02/2024 - 01/2018
2	bis(p-chlorophenyl)acetic acid (DDA)IBA 01/2023 - 01/2021
2	Single-Domain AntibodiesIBA 01/2021 - 12/2013
2	Long Noncoding RNAIBA 01/2020 - 03/2016
2	Protein Isoforms (Isoforms)IBA 01/2020 - 05/2008
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2020 - 10/2015
2	Cysteine Proteases (Cysteine Protease)IBA 03/2019 - 12/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2018 - 01/2002
2	Dihydrotachysterol (AT 10)IBA 12/2018 - 03/2013
2	N-acetyltryptophanamide (NATA)IBA 12/2018 - 08/2014
2	Adenosine Triphosphate (ATP)IBA 10/2015 - 12/2008
2	Membrane Proteins (Integral Membrane Proteins)IBA 08/2015 - 06/2012
2	N-acetyltalosaminuronic acid (NAT)IBA 04/2015 - 08/2014
2	Methionine (L-Methionine)FDA Link 07/2013 - 05/2011
1	dagrocoratIBA 02/2024
1	SuspensionsIBA 10/2023
1	acrylic acid (acrylate)IBA 10/2023
1	Ethylene Glycol (Monoethylene Glycol)IBA 10/2023
1	CollagenIBA 10/2023
1	PolymersIBA 10/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2023
1	Urethane (Ethyl Carbamate)IBA 10/2023
1	Drug CombinationsIBA 10/2023
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 01/2023
1	Bacterial Proteins (Bacterial Protein)IBA 01/2023
1	MannosidasesIBA 12/2022
1	Mannose (D-Mannose)IBA 12/2022
1	Polysaccharides (Glycans)IBA 12/2022
1	LipidsIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2021
1	GW 4869IBA 01/2021
1	Transfer RNA (tRNA)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	CatalaseIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	VaccinesIBA 01/2019
1	NF-kappa B (NF-kB)IBA 12/2018
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 12/2018
1	GlycogenIBA 12/2018
1	Satellite RNA (Satellite RNAs)IBA 10/2018
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2018
1	2- (4- acetoxyphenyl)- 2- chloro- N- methylethylamineIBA 01/2018
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2018
1	ponatinibIBA 01/2017

Therapy/Procedure

7	Therapeutics 01/2021 - 02/2011
1	Radiotherapy 12/2022
1	Drug Therapy (Chemotherapy) 01/2020